title: American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
abstract: OBJECTIVE
  To describe both minimum requirements for a site conducting quality clinical trials and attributes of an exemplary site.
  
  
  METHODS
  Minimum requirements and exemplary attributes were selected based on literature review, prevailing regulatory requirements, and consensus among a group of community and academic clinical researchers.
  
  
  RESULTS
  To provide guidance to oncologists who wish to conduct patient-oriented research, recommendations are made to assist in the development and implementation of high-quality research programs with the priority of protecting the welfare and rights of trial participants. A quality research site complies with the International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) guidelines, the accepted international ethical and scientific quality standards for designing, conducting, recording, and reporting trials involving human participants. Recognizing that many research sites conduct clinical trials in compliance with accepted GCP standards, supplemental attributes of an exemplary research site that exceed the GCP criteria are also described. These attributes include diversification of clinical trial mix, high accrual activity, participation in the trial development process, maintenance of high educational standards, quality assurance, multidisciplinary involvement in the clinical trial process, and promotion of clinical trial awareness programs.
  
  
  CONCLUSIONS
  Meeting the minimum criteria ensures conduct of quality clinical trials; however, some sites may wish to incorporate value-added attributes to exceed GCP compliance. These attributes are proposed as performance goals rather than requirements, recognizing that all sites conducting research will not necessarily meet each attribute but may still conduct high-quality clinical trials.
authors.affiliation: Michiana Hematology Oncology, South Bend, IN, USA.
authors.forename: Robin
authors.initials: R
authors.lastname: Zon
authors.forename: Neal J
authors.initials: NJ
authors.lastname: Meropol
authors.forename: Robert B
authors.initials: RB
authors.lastname: Catalano
authors.forename: Richard L
authors.initials: RL
authors.lastname: Schilsky
mesh_terms: D035843:Biomedical Research / Q000592:standards*; D002986:Clinical Trials as Topic / Q000592:standards*; D017408:Guidelines as Topic / Q000592:standards*; D006805:Human Experimentation / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D011785:Quality Assurance, Health Care / Q000592:standards*; D012107:Research Design; D012955:Societies, Medical; D014481:United States